Cold & Cough Remedies (Pharmacies) - Norway

Revenue in the Cold & Cough Remedies market is projected to reach US$10.25m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.98%, resulting in a market volume of US$11.87m by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$1.86 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Norway is experiencing steady growth due to customer preferences for over-the-counter remedies, increasing awareness of health and wellness, and a growing aging population. Customer preferences in Norway are shifting towards self-care and over-the-counter remedies for common ailments such as cold and cough. This trend is driven by the convenience and accessibility of purchasing these remedies from pharmacies without the need for a prescription. Customers prefer to treat minor illnesses at home rather than visiting a doctor, which contributes to the demand for cold and cough remedies in pharmacies. The market is also influenced by the increasing awareness of health and wellness among the Norwegian population. People are becoming more proactive in maintaining their health and are seeking preventive measures to avoid falling sick. This includes the use of cold and cough remedies to alleviate symptoms and prevent the illness from worsening. The demand for natural and herbal remedies is also on the rise, as customers are becoming more conscious of the ingredients in the products they use. The aging population in Norway is another factor driving the growth of the Cold & Cough Remedies market. As people age, their immune systems weaken, making them more susceptible to cold and cough. The elderly population seeks remedies to manage their symptoms and improve their quality of life. This demographic segment contributes significantly to the demand for cold and cough remedies in pharmacies. In addition to customer preferences, there are local special circumstances in Norway that contribute to the development of the Cold & Cough Remedies market. The country experiences long and harsh winters, which increases the likelihood of people falling sick with cold and cough. The cold climate and limited sunlight also affect the immune system, making people more vulnerable to illnesses. As a result, the demand for cold and cough remedies is higher in Norway compared to countries with milder climates. Underlying macroeconomic factors also play a role in the growth of the Cold & Cough Remedies market in Norway. The country has a strong economy with a high standard of living, allowing people to afford healthcare products and remedies. The government also provides a robust healthcare system, ensuring access to healthcare services and medications. These factors contribute to the overall demand for cold and cough remedies in pharmacies. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Norway is developing due to customer preferences for over-the-counter remedies, increasing awareness of health and wellness, the growing aging population, local special circumstances, and underlying macroeconomic factors. The market is expected to continue growing as people prioritize self-care and seek preventive measures to maintain their health and well-being.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.